Medtronic, Inc.

710 Medtronic Pkwy
Minneapolis, MN 55432-5604
USA
Phone:
763-514-4000
Fax:
763-514-4879
www.medtronic.com

Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.

Related Content

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators
This is a brief overview of updates on...
read more
Medtronic Presents Positive Renal Denervation Results at EuroPCR 2019
News | Renal Denervation | May 23, 2019
Medtronic Presents Positive Renal Denervation Results at EuroPCR 2019
Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial at the...
read more
Medtronic Launches Telescope Guide Extension Catheter
Technology | Guidewires | May 21, 2019
Medtronic Launches Telescope Guide Extension Catheter
Medtronic plc announced its entrance into the guide extension catheter market with the global launch of the Telescope...
read more
Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019
Studies Find Race and Gender Disparities in Implantable Heart Devices
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, includ
read more
A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system showed it can be implanted with no major complications, and can sense, pace and defibrillate the heart.

Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.

News | May 13, 2019
First-in-human Study Positive of Medtronic Extravascular ICD System
May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Def
read more
Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
News | EP Mapping and Imaging Systems | May 09, 2019
Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF),...
read more
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients...
read more
FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic
Technology | Leads Implantable Devices | May 06, 2019
FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic
Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI SureScan left...
read more
Medtronic Receives FDA Approval for CareLink SmartSync Device Manager
Technology | EP Device Monitoring Systems | May 02, 2019
Medtronic Receives FDA Approval for CareLink SmartSync Device Manager
Medtronic announced the company has received U.S. Food and Drug Administration (FDA) approval for the CareLink...
read more
Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting
News | Heart Valve Technology | April 03, 2019
TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut transc
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init